Market

Quarterly Results

You can view the Quarterly Results for the last 5 years.

QUARTERLY RESULTS

AstraZeneca Pharma India Ltd.

GO
Market Cap. ( ₹ in Cr. ) 21961.25 P/BV 32.33 Book Value ( ₹ ) 271.74
52 Week High/Low ( ₹ ) 10691/6220 FV/ML 2/1 P/E(X) 189.75
Book Closure 18/07/2025 EPS ( ₹ ) 46.30 Div Yield (%) 0.36
(₹ in Crs.)

ParticularsMar 25Dec 24Sep 24Jun 24Mar 24
Net Sales/Income from operations480.48440.29408.00387.52383.20
Total Income From Operations480.48440.29408.00387.52383.20
      
EXPENDITURE     
Consumption of Raw Materials94.2569.8877.1545.8533.62
Purchase of Traded Goods287.86228.76251.87240.3374.98
Increase/Decrease in Stocks-122.50-51.61-103.09-55.74104.95
Employees Cost66.0762.3768.0460.9657.98
Depreciation17.699.079.323.913.76
Admin. And Selling Expenses22.0222.740.000.000.00
Provisions And Contingencies0.00-0.170.000.000.00
Other Expenses46.4131.3361.4858.0462.28
Total Expenses411.80372.37364.77353.35337.57
      
P/L Before Other Inc. , Int., Excpt. Items & Tax68.6867.9243.2234.1745.62
Other Income16.157.988.158.358.66
P/L Before Interest, Excpt. Items & Tax84.8375.9051.3842.5254.29
Interest0.680.330.340.11-0.07
P/L Before Exceptional Items & Tax84.1575.5751.0342.4154.35
Exceptional Items-5.68-33.550.00-57.560.00
P/L Before Tax78.4742.0251.03-15.1654.35
Tax20.2211.1712.60-3.3714.88
P/L After Tax from Ordinary Activities58.2530.8538.43-11.7939.48
Net Profit/Loss For the Period58.2530.8538.43-11.7939.48
      
Equity Share Capital5.005.005.005.005.00
EPS Before Extra Ordinary *     
Basic EPS (Rs.)23.3012.3415.37-4.7215.79
Diluted EPS (Rs.)23.3012.3415.37-4.7215.79
EPS After Extra Ordinary *     
Basic EPS (Rs.) 23.3012.3415.37-4.7215.79
Diluted EPS (Rs.) 23.3012.3415.37-4.7215.79
      
PBITOE Margin (%)14.2915.4210.598.8111.90
PBTE Margin (%)17.5117.1612.5010.9414.18
PBT Margin (%)16.339.5412.50-3.9114.18
PAT Margin (%)12.127.009.41-3.0410.30